BioNTech
BNTX
BNTX
193 hedge funds and large institutions have $1.77B invested in BioNTech in 2020 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+46
Holders Change %
+31.29%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
81
Increased
43
Reduced
46
Closed
34
Calls
$181M
Puts
$193M
Net Calls
-$11.6M
Net Calls Change
+$78.7M
Top Buyers
| 1 |
BlackRock
New York
|
$54.5M |
| 2 |
Primecap Management
Pasadena,
California
|
$377M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$128M |
| 4 |
Morgan Stanley
New York
|
$25.2M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
$17.2M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$236M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
$748K |
| 3 |
AG
Artal Group
Luxembourg
|
$81.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
$47.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
$1.67M |
